Ghrelin as a potential molecular marker of adrenal carcinogenesis: In vivo and in vitro evidence

被引:8
作者
Komarowska, Hanna [1 ]
Rucinski, Marcin [2 ]
Tyczewska, Marianna [2 ]
Sawicka-Gutaj, Nadia [1 ]
Szyszka, Marta [2 ]
Hernik, Aleksandra [1 ]
Klimont, Anna [1 ]
Milecka, Paulina [2 ]
Migasiuk, Laura [1 ]
Biczysko, Mateusz [3 ]
Idasiak-Piechocka, Ilona [4 ]
Karczewski, Marek [5 ]
Ruchala, Marek [1 ]
机构
[1] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland
[2] Poznan Univ Med Sci, Dept Histol & Embryol, Poznan, Poland
[3] Poznan Univ Med Sci, Dept Gen Endocrinol & Gastroenterol Surg, Poznan, Poland
[4] Poznan Univ Med Sci, Dept Nephrol Transplantol & Internal Med, Poznan, Poland
[5] Poznan Univ Med Sci, Dept Gen & Transplantat Surg, Poznan, Poland
关键词
adrenal; adrenocortical carcinoma; ghrelin; IGF2; proliferative factor; ADRENOCORTICAL CARCINOMA; GENE-EXPRESSION; CELL-LINES; ACYLATED PEPTIDE; RNA DEGRADATION; BREAST-CANCER; GROWTH; TUMORS; RECEPTOR; TISSUES;
D O I
10.1111/cen.13725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ContextAdrenal tumours belong to one of the most prevalent neoplasms. It is a heterogeneous group with different aetiology, clinical manifestation and prognosis. Its histopathologic diagnosis is difficult and identification of differentiation markers for tumorigenesis is extremely valuable for diagnosis. DesignTo assess ghrelin expression and the relationship among ghrelin, IGF2 and the clinicopathological characteristics of adrenal tumours. To investigate the influence of ghrelin on ACC cell line proliferation. Materials and methodsExpression of ghrelin and IGF2 in a total of 84 adrenal tissue samples (30 adenoma, 12 hyperplasia, 8 myelolipoma, 20 pheochromocytoma, 7 carcinoma and 7 unchanged adrenal glands) were estimated. Every operated patient from whom samples were obtained underwent clinicopathological analysis. All the parameters were compared among the groups examined and correlations between these were estimated. H295R cell line was incubated with ghrelin to assess its effect on proliferation and migration rate. ResultsThe highest ghrelin expression was observed in carcinoma samples and the lowest in the control group. Ghrelin expression was 21 times higher in carcinoma (P=.017) and 2.4 times higher in adenoma (P=.029) compared with controls. There were no statistically significant differences between myelolipoma (P=.093) and pheochromocytoma (P=.204) relative to the control. Ghrelin level was significantly higher in carcinoma compared to adenoma (P=.049) samples. A positive correlation between ghrelin and IGF2 expression was observed only in myelolipoma (P=.001). Ghrelin at concentrations of 1x10(-6)mol/L and 1x10(-8)mol/L significantly stimulated proliferation and migration rate in the H295R cell line. ConclusionGhrelin appears to be an essential factor in driving adrenal tumours development.
引用
收藏
页码:36 / 45
页数:10
相关论文
共 35 条
[1]   Expression of ghrelin and ghrelin functional receptor in human pituitary adenomas [J].
Andrusiewicz, Miroslaw ;
Komarowska, Hanna ;
Skibinska, Izabela ;
Chmielewska, Malgorzata ;
Jaskula-Switek, Magdalena ;
Liebert, Wlodzimierz ;
Wasko, Ryszard ;
Kotwicka, Malgorzata .
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (03) :163-169
[2]   Weiss system revisited - A clinicopathologic and immunohistochemical study of 49 adrenocortical tumors [J].
Aubert, S ;
Wacrenier, A ;
Leroy, X ;
Devos, P ;
Carnaille, B ;
Proye, C ;
Wemeau, JL ;
Lecomte-Houcke, M ;
Leteurtre, E .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1612-1619
[3]   Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors [J].
Barzon, L ;
Pacenti, M ;
Masi, G ;
Stefani, AL ;
Fincati, K ;
Palù, G .
ONCOLOGY, 2005, 68 (4-6) :414-421
[4]   Adrenal incidentaloma in adults - management recommendations by the Polish Society of Endocrinology [J].
Bednarczuk, Tomasz ;
Bolanowski, Marek ;
Sworczak, Krzysztof ;
Gornicka, Barbara ;
Cieszanowski, Andrzej ;
Otto, Maciej ;
Ambroziak, Urszula ;
Pachucki, Janusz ;
Kubicka, Eliza ;
Babinska, Anna ;
Koperski, Lukasz ;
Januszewicz, Andrzej ;
Prejbisz, Aleksander ;
Gorska, Maria ;
Jarzab, Barbara ;
Hubalewska-Dydejczyk, Alicja ;
Glinicki, Piotr ;
Ruchala, Marek ;
Kasperlik-Zaluska, Anna .
ENDOKRYNOLOGIA POLSKA, 2016, 67 (02) :234-258
[5]   Pathogenesis of adrenocortical cancer [J].
Bertherat, Jerome ;
Bertagna, Xavier .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (02) :261-271
[6]   Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines [J].
Cassoni, P ;
Papotti, M ;
Ghè, C ;
Catapano, F ;
Sapino, A ;
Graziani, A ;
Deghenghi, R ;
Reissmann, T ;
Ghigo, E ;
Muccioli, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1738-1745
[7]   Impact of RNA degradation on gene expression profiles:: Assessment of different methods to reliably determine RNA quality [J].
Copois, Virginie ;
Bibeau, Frederic ;
Bascoul-Mollevi, Caroline ;
Salvetat, Nicolas ;
Chalbos, Patrick ;
Bareil, Corinne ;
Candeil, Laurent ;
Fraslon, Caroline ;
Conseiller, Emmanuel ;
Granci, Virginie ;
Maziere, Pierre ;
Kramar, Andrew ;
Ychou, Marc ;
Pau, Bernard ;
Martineau, Pierre ;
Molina, Franck ;
Del Rio, Maguy .
JOURNAL OF BIOTECHNOLOGY, 2007, 127 (04) :549-559
[8]   The challenge of developmental therapeutics for adrenocortical carcinoma [J].
Costa, Ricardo ;
Carneiro, Benedito A. ;
Tavora, Fabio ;
Pai, Sachin G. ;
Kaplan, Jason B. ;
Chae, Young Kwang ;
Chandra, Sunandana ;
Kopp, Peter A. ;
Giles, Francis J. .
ONCOTARGET, 2016, 7 (29) :46734-46749
[9]   Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans [J].
Date, Y ;
Kojima, M ;
Hosoda, H ;
Sawaguchi, A ;
Mondal, MS ;
Suganuma, T ;
Matsukura, S ;
Kangawa, K ;
Nakazato, M .
ENDOCRINOLOGY, 2000, 141 (11) :4255-4261
[10]   Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway [J].
Delhanty, P. J. D. ;
van Koetsveld, P. M. ;
Gauna, C. ;
van de Zande, B. ;
Vitale, G. ;
Hofland, L. J. ;
van der Lely, A. J. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (01) :E302-E309